Clinical Course, Immunogenicity, and Efficacy of BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection in Liver Transplant Recipients

Clinical Course, Immunogenicity, and Efficacy of BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection in Liver Transplant Recipients

Background. Immunocompromised individuals have been excluded from landmark studies of messenger RNA vaccinations for severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). In such patients, the response to vaccination may be blunted and may wane more quickly compared with immunocompetent...

Full description

Bibliographic Details
Main Authors: Eunice X. Tan, MBBS, MMED, MRCP, Wen Hui Lim, MBBS, Elizabeth Thong, MBBS, Jean-Marc Chavatte, PhD, Jinyan Zhang, MBBS, Jonathan Lim, MBBS, Jocelyn Y. Jin, PhD, Daniel R.X. Lim, MBBS, Jaclyn Y.T. Kang, MBBS, Ansel Shao Pin Tang, MBBS, Kai En Chan, MBBS, Caitlyn Tan, MBBS, Shi Ni Tan, MBBS, Benjamin Nah, MBBS, MRCP, Daniel Q. Huang, MBBS, MMED, MRCP, Lin-Fa Wang, PhD, Paul A. Tambyah, MBBS, Diplomate ABIMID, Jyoti Somani, AB, MD, Diplomate ABIMID, Barnaby Young, MSc, MB, BChir, MRCP, DLSHTM, Mark D. Muthiah, MBBS, MRCP, MMed
Format: Article
Language:English
Published: Wolters Kluwer 2023-10-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001537

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001537

Similar Items